Navigation Links
Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
Date:2/26/2013

869,95214,585Goodwill

442,60038,213Deferred tax assets, net, non-current

74,850-Deferred financing costs

16,576-Other long-term assets

3,66287Total assets

$
,966,493$
253,573LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities:Accounts payable

$
5,887$
5,129Accrued liabilities

104,66634,783Current portion of long-term debt 

29,688-Income taxes payable

39,884-Deferred tax liability, net

275-Purchased product rights liability

-4,500Liability under government settlement

-7,320Deferred revenue

1,1381,138Total current liabilities

191,53852,870Deferred revenue, non-current

6,7767,915Long-term debt, less current portion 

427,073-Contingent consideration

34,800-Deferred tax liability, net, non-current

178,393-Other non-current liabilities

6,621-Total shareholders' equity 

1,121,292192,788Total liabilities and shareholders' equity 

$
,966,493$
253,573 JAZZ PHARMACEUTICALS PLC RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES  (In thousands, except per share amounts)  (Unaudited) Three Months EndedYear EndedDecember 31,December 31,2012201120122011 GAAP income from continuing operations 

$
,206$
37,473$
261,149$
24,984 Intangible asset amortization 

21,9071,86265,3517,448 Share-based compensation expense 

8,32210,94623,00620,704 Acquisition accounting inventory fair value step-up 

2,118-16,794- Transaction and integration costs 

1,1295,27118,82111,245 Restructuring charges 

609-2,789- Change in fair value of contingent consideration 

(1,400)-(300)- Loss on extinguishment of debt 

-150-1,247 Other non-cash expense (income) 

'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... VPII Escrow Corp., a newly formed wholly owned Canadian ... approximately $3.2 billion aggregate principal amount of senior unsecured ... 2021 and in 2023, with final tranching determined at ... net proceeds from the offering, together with proceeds from ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
...  GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 2011 on Thursday, March 15, 2012, before the U.S. financial ... and conference call at 10:00 a.m. EDT to discuss the ... outlook. To listen to the live conference ...
... release of System 7 – the next generation of heavy ... such as hip and knee replacements. System 7 offers the ... and highest performing power tool system ever from Stryker. ... heavy duty power tools in 1982, and has built a ...
Cached Medicine Technology:GenVec to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012 2Stryker Launches Next Generation Heavy Duty Surgical Power Tools 2
(Date:6/19/2013)... Middle market merger and acquisition (M&A) ... as cash rich buyers seek to place their capital ... M&A transactions have a good deal in common. The ... history and quality of the target company’s earnings. Potential ... due diligence involves a middle market company, whose value ...
(Date:6/19/2013)... Faith4Kidz is starting a new fundraising effrt to ... like help showing support for kids to learn how to ... Check out the website, http://www.gracenfaith.com to see Faith4Kidz ... white and blue stars as a symbol of our country ... well as the stars we should encourage our children to ...
(Date:6/19/2013)... Francisco, CA (PRWEB) June 19, 2013 ... Pharmacy and Drug Retailer industry has been growing ... $42.7 billion in 2013. Many factors have supported the ... demand for drugs retailed by drugstores; relatively higher drug ... , Additionally, the government's support for the development of ...
(Date:6/18/2013)... June 19, 2013 Consumer injury attorney ... other law firms have launched a new website for ... by dialysis. The website is http://www.DialysisLawsuitAttorneys.com . , ... to begin offering legal services to people who may ... and NaturaLyte, or who may have suffered injuries due ...
(Date:6/18/2013)... June 19, 2013 oBand Surgery Centers, ... are holding complimentary weight loss seminars in Los Angeles ... can be accessed at their official website. oBand Surgery ... recovery time. Their highly skilled panel of surgeons and ... , A senior executive working with oBand Surgery ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 2Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 2Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 4Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2
... has a love-hate relationship with iron. Just the right amount is ... brain diseases like Alzheimer,s and Parkinson,s. Science knows ... women. These higher levels may be part of the explanation for ... But why do women have less iron in ...
... to perform everyday activities. This is not primarily due to ... was previously believed new research from the University of ... initiate and complete a task towards a specific goal. ... normally results in a degree of paralysis in the lower ...
... will discuss scientific studies of mutual interests and explore ... Oct. 24-26. The Ohio State University Medical Center is ... first of its kind between the two countries. , ... countries are expected to speak at the event that ...
... providers assess blood and tissue type as well as ... research indicates that checklist might also need to include ... shown the time of day transplant surgery is performed ... dysfunctional internal clocks is the first correlating circadian clocks ...
... 4 (HealthDay News) -- Readmission rates have increased in ... the country,s most elite academic medical centers, new research ... to the hospital within 30 days of being discharged ... as hospitals brace for penalties -- reduced payments for ...
... shows that exposure to stressors in the Neonatal Intensive ... brain structure and function of very preterm infants. According ... Neurology , a journal published by Wiley-Blackwell on behalf ... infants who experienced early exposure to stress displayed decreased ...
Cached Medicine News:Health News:Hysterectomy is associated with increased levels of iron in the brain 2Health News:Hysterectomy is associated with increased levels of iron in the brain 3Health News:Children with spina bifida need personal 'starter' 2Health News:Ohio State organizes research sharing between Brazil, US 2Health News:Circadian clock may impact organ transplant success 2Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 2Health News:Hospital Readmission Rates on the Rise in Older Adults: Study 3Health News:Preterm infants exposed to stressors in NICU display reduced brain size 2
Inquire...
This fixed-volume digital micropipet is used to accurately measure and transfer 20 microliters of solution....
20L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: